Bridge-Enhanced (TM) ACL Repair Clinical Trial Overview

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the ACL Program

  • 617-355-3501
  • International: +1-617-355-5209
  • Locations

Every year, approximately 400,000 anterior cruciate ligament (ACL) injuries occur. ACL reconstruction surgery is one of the most common orthopedic procedures in the United States. Unlike other ligaments, the ends of a torn ACL do not reconnect. During an ACL reconstruction, an orthopedic surgeon removes the ends of the torn ACL and replaces them with a graft, usually from two of the patient’s hamstring tendons. Although most patients are able to return to sports, the ACL re-tear rate can be as high as 20 percent for teens. Up to 80 percent of patients develop arthritis 15 to 20 years after surgery.

What is bridge-enhanced (TM) ACL repair?

The new technique, bridge-enhanced (TM) ACL repair (BEAR(TM)), uses stitches and a bridging scaffold (a sponge injected with the patient’s blood) to stimulate healing of the torn ACL. We have tried the procedure in animal models and 10 patients. The goal of the current study is to determine if the new technique is as good as ACL reconstruction for a larger number of patients.

What are the differences between ACL reconstruction and bridge-enhanced (TM)
ACL repair?

ACL reconstruction:

•   standard care for ACL tears, proven to be safe and effective
•   requires incision to harvest the graft; other work done arthroscopically
•   requires graft harvest of patient’s own tendon
•   remaining ACL tissue is removed

Bridge-enhanced ACL repair (BEAR) at Boston Children's Hospital

Bridge-enhanced (TM) repair:

•   experimental use of a bridging scaffold with some unknown risks and benefits
•   requires incision to insert scaffold; other work done arthroscopically
•   no graft harvest of patient’s tendon
•   remaining ACL tissue is preserved

Learn more about the BEAR (TM) clinical trial

* We are currently enrolling patients in the BEAR(TM) II study.  To learn more about the BEAR II trial or to schedule an appointment with a BEAR(TM) trial physician, please call 617-355-3501 or email bear.trial@childrens.harvard.edu.

Read about Corey - the first patient who had the BEAR(TM) surgery.

Download the brochure or to learn more about the BEAR(TM) trial email us at bear.trial@childrens.harvard.edu.

Read BEAR(TM) published research.

Learn more about Boston Children's ACL research.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close